VOYA Investment Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-38,780
Closed -$681K 2856
2021
Q3
$681K Hold
38,780
﹤0.01% 1845
2021
Q2
$376K Buy
+38,780
New +$365K ﹤0.01% 2261

Other funds holding TRIL

VOYA Investment Management's TRIL Position: Q4 2021 in Review

VOYA Investment Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 38,780 shares — an estimated $681K sold.

VOYA Investment Management first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $681K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

  • VOYA Investment Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
  • VOYA Investment Management sold 38,780 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $681K.
  • VOYA Investment Management first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
  • VOYA Investment Management's Trillium Therapeutics Inc. position peaked at $681K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on VOYA Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.